Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review

Study shows that Roche’s investigational drug for Alzheimer’s disease removes amyloid plaques from the brain

Roche has announced the publication of a study demonstrating that its monoclonal antibody gantenerumab removes amyloid plaques from the brain of patients with Alzheimer’s disease. The study “Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab” is published in the October issue of Archives in Neurology...

Read more >>

More pharmaceutical & life science news:

Victoza® now available to people with type 2 diabetes in China
Victoza® (liraglutide injection), is now commercially available in China...

AstraZeneca increases investment in China with new $200 million manufacturing facility
AstraZeneca announced a $200 million investment in a new manufacturing facility...

FDA approves Merck’s JUVISYNC™ (sitagliptin and simvastatin) tablets
Multiple national guidelines recommend that patients with type 2 diabetes be treated for cholesterol...

Cialis® for once daily use now FDA approved
Cialis for once daily use is the first and only medication approved to treat men with both ED and BPH...

Teva UK Limited launches Olanzapine range
Teva UK Ltd announce the off-patent launch of generic Olanzapine Teva Film-Coated Tablets & Olanzapine Teva Orodispersible Tablets...

Merck announces retirement of Chairman and former CEO Richard T. Clark
Merck announced that Richard T. Clark, chairman, will retire 1st December ...

Gilead and Boehringer Ingelheim sign license agreement for novel HIV non-catalytic integrase inhibitors
Gilead Sciences, Inc. and Boehringer Ingelheim have entered into a licensing agreement...

Lundbeck appoints three Vice Presidents in Supply Operations & Engineering
Lundbeck has appointed Kristian Sibilitz, Christian Houborg and Lene Andersen as Vice Presidents in Supply Operations & Engineering...

FDA accepts New Drug Application filing for ridaforolimus, investigational mTOR inhibitor
The FDA accepted for filing and review the New Drug Application for ridaforolimus...

AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd regarding US SEROQUEL XR® patent litigation
AstraZeneca enters into a settlement agreement with Accord Healthcare, Inc. & Intas Pharmaceuticals Ltd...

Events, conferences & exhibitions:

PDA’s 6th Annual Global Conference on Pharmaceutical Microbiology
17 - 21 October 2011, Bethesda, USA

BioProduction 2011
19 - 20 October 2011, Berlin, Germany

Process Validation for Drugs and Biologics
26 - 27 October 2011, Berlin, Germany

BIA Research and Development Conference
27 October 2011, London, UK

European Pharmaceutical Pricing & Reimbursement
31 October - 1 November 2011, Basel, Switzerland

BIT’s 1st Annual Symposium of Drug Delivery Systems 2011
3 - 5 November 2011 Liaoning, China

BIT’s 9th Annual Congress of International Drug Discovery Science and Technology
3 - 6 November 2011, Shenzden, China

BIT’s 2nd Annual World Congress of NanoMedicine 2011
3 - 6 November 2011, Guangdong, China

IFPAC 2012
22 - 25 January 2012 Baltimore, USA

Avoid process failure and improve product quality

How many batches do you scrap due to unresolved process deviations each year? How much of your stock sits in WIP?

Even just a one-percent reduction in scrap and waste can save the average pharmaceutical manufacturing operation millions of dollars each year.

Now you can identify trends or potentially harmful drifts in a process as it is running, rather than off-line, with the Unscrambler X Process Pulse. This real-time multivariate process monitoring software is powerful yet easy to use. It allows you to detect and correct issues before they become problems.

The Unscrambler X Process Pulse is affordable, easy to set up and can be used in R&D, quality control and manufacturing environments with a wide range of data types. The software can run as a stand-alone application or be integrated into an existing control system.

Full feature list, brochure and free trial here >>

Company directory

Our new look directory includes hundreds of organisations, plus the following Premium listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
Bio-Optronics, Inc.
- bioMérieux
BioTek Instruments, Inc.
- BMG LABTECH GmbH
- Bruker Daltonik GmbH
- CAMO Software AS
- Cellular Dynamics International, Inc.
CI Precision
- Cisbio Bioassays
- Colder Products Company
- Comark Instruments
DCA Design International
- DiscoveRx Corporation
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- IDBS
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau
- Randox Pharma Services
- Rapid Micro Biosystems
- Sapient Discovery
- Smithers Viscient
- Synbiosis
- Syngene
- TOPRA
- Watson-Marlow Pumps Group

Add your company >>


Join European Pharmaceutical Review on LinkedIn


Follow European Pharmaceutical Review on Twitter


Like European Pharmaceutical Review on Facebook